GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telescope Innovations Corp (XCNQ:TELI) » Definitions » Valuation Rank

Telescope Innovations (XCNQ:TELI) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Telescope Innovations Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Telescope Innovations Valuation Rank Related Terms

Thank you for viewing the detailed overview of Telescope Innovations's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Telescope Innovations Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telescope Innovations Corp (XCNQ:TELI) » Definitions » Valuation Rank
Comparable Companies
TSXV:QPT TSX:AEZS XCNQ:BLAB XCNQ:ASEP XCNQ:MDMA XCNQ:PHRM XCNQ:COOL TSXV:KNE NEOE:AWKN XCNQ:BETR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
TELIF:USA
Address
301 – 2386 East Mall, Vancouver, BC, CAN, V6T 1Z3
Website
https://www.telescopeinnovations.com
Telescope Innovations Corp is a technology company that intends to focus on development as a Contract Research Organization (CRO) to develop intellectual property, contract research, and building automation products. The Company has one operating segment that generates revenues from two revenue streams, contract research services and sale of automation products.
Executives
Jason Hein Director, Senior Officer
Alidad Pejman Director